Strong TripleTOF 5600 Sales Drive Mid-Teens Q2 Growth at AB Sciex

Saying that the 5600 "has exceeded expectations," Danaher president and CEO Larry Culp suggested that in the first half of the year AB Sciex "probably took a little bit of share in certain corners" of the mass spec market.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.